Where Brands Lead, Rx Prices Follow
Managed care and pharmacy benefit management were supposed to drive drug prices down by creating customers with enormous leverage. But a recent study of pricing by Express Scripts, a PBM, suggests that where a drug company has a strong franchise with a leading brand, managed care is relatively powerless to drive discounts.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.